Nancy Martinez, Business Development Manager at GTP Bioways CDMO, is excited to participate in the Bioprocess International Europe 2024 conference in Vienna, Austria from the 9th to the 12th of April. This event is set to attract more than 3000 global attendees, including representatives from biotech companies, major pharmaceutical corporations, and service providers.
BioProcess International Europe serves as a pivotal meeting point for industry experts, showcasing the latest innovations in all phases of biopharmaceutical development and manufacturing. For instance, the conference’s agenda covers five key areas critical for the biopharmaceutical industry:
- Cell Line Development
- Cell Culture and Upstream Process Development (USP)
- Recovery and Purification (DSP)
- Manufacturing Strategy & Industry
- Cell & Gene Therapy
At BPI 2024, attendees will have the chance to explore cutting-edge science, innovative technologies, and engage with influential contacts. It’s a perfect occasion for networking and gaining insights to drive industry progress. Nancy will be there, ready to discuss your project and future partnerships.
Discover our biologics CDMO capacities at BioProcess International Europe
Nancy will be pleased to introduce you to our continuum of CDMO services for the manufacturing of biologics. With capabilities tailored to meet your needs, we have expertise in developing and manufacturing biologics and antibody-drug conjugates (ADCs). From Cell Line Development to aseptic Fill & Finish, our support spans the entire process, including process development and GMP manufacturing in microbial and mammalian systems.
Schedule a meeting with her to know more about how GTP Bioways CDMO can support your projects and help driving your biologics development and production forward.
BioProcess International Europe 2024
Day(s)
:
Hour(s)
:
Minute(s)
:
Second(s)
Contact our team to request a meeting.
